According to GlobalData, global sales for Trodelvy are expected to reach nearly $3bn by 2029, driven by expansion into new indications such as NSCLC.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,